4
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Nosocomial pneumonia

Pages 115-126 | Published online: 04 Dec 2011

References

  • American Thoracic Society Consensus Statement: Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. Am. J. Resp. Crit. Care Med. 19954; 153: 1711-1725.
  • Craven DE, Steger KA: Epidemiology of nosocomial pneu-monia: New perspectives on an old disease. Chest 1995; 108(suppl): 1S–16S.
  • Tablan OC, Anderson IT Arden NH, et al. Guideline for prevention of nosocomial pneumonia. Infect. Control Hospital Epid. 1994; 15: 588.
  • Fagon J-Y, Chastre J, Domart Y, et al. Nosocomial pneu-monia in patients receiving continuous mechanical ventil-lation. Am. Rev. Resp. Dis. 1989; 139: 877.
  • Girou E, Stephan F, Novara A, et al. Risk factors and outcome of nosocomial infections: Results of a matched case-control study of ICU patients. Am. J. Resp. Crit. Care Med. 1998; 157: 1151–1158.
  • Bueno-Cavanillas A, Delgado-Rodriguez M, Lopez-Luque A, Schaffino-Cano S. Galvez-Vargas R. Influence of noso-comial infection on mortality rate in an intensive care unit. Crit. Care Med. 1994; 22: 55–60.
  • Boyce JM, Potter-Bynoe G, Dziobek L, Solomon SL. Nosocomial pneumonia in Medicare patients. Hospital costs and reimbursement patterns under the prosepctive payment system. Arch. Intern. Med. 1991; 151: 1109–1114.
  • Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk fators for ventilator-associated pneumonia in critically ill patients. Ann. Intern. Med. 1998; 129: 433–440.
  • Drakylovic MB, Torres A, Bauer, T, et al. Supine body pos-ition as a risk factor for nosocomial pneumonia in mechan-ically ventilated patients: A randomized trial. Lancet 1999; 354: 1851–1858.
  • Fernandez-Crehuet R, Diaz-Molina C, de Irala J, et al. Nosocomial infection in an intensive-care unit: Identification of risk factors. Infect. Control Hosp. Epidemiol. 1997; 18: 825–830.
  • Leal-Noval SR, Marquez-Vacaro JA, Garcia-Curet A, et al. Nosocomial pneumonia in patients undergoing heart surg-ery. Crit. Care Med. 2000; 28: 935–940.
  • Kollef MH, Von Harz B, Prentice D, et al. Patient transport from intensive care increases the risk of developing ventilator-associated pneumonia. Chest 1997; 112: 765–773.
  • Fagon J-Y, Chastre J, Vuagnat A, et al. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996; 175: 866–869.
  • Rouby JJ, DeLassale EM, Poete P, et al. Nosocomial bronchopneumonia in the critically ill: Histologic and bacteriologic aspects. Am. Rev. Resp. Dis. 1992; 146: 1059–1066.
  • Fagon JY, Chastre J, Hance AJ, et al. Detection of nosocomial lung infection in ventilated patients: Use of a protected specimen brush and quantitative culture techniques in 147 patients. Am. Rev. Resp. Dis. 1988; 138: 110–116.
  • Fagon J-Y, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. Ann. Intern. Med. 2000; 132: 621–630.
  • Bryan CS, Reynolds KL. Bacteremic nosocomial pneu-monia. Am. Rev. Resp. Dis. 1984; 129: 688–691.
  • Shales DM, Ledeman MM, Chmielewski R, et al. Elastin fibers in the sputum of patients with necrotizing pneumonia. Chest 1983; 83: 885–889.
  • Kirkland SH, Corkey DE, Winterbauer RH, et al. The diag-nosis of ventilator-associated pneumonia. A comparison of histologic, microbiologic and clinical criteria. Chest 1997; 112: 445–457.
  • Niederman MS, Tones A, Summer W. Invasive diagnostic testing is not needed routinely to manage suspected ventilator-associated pneumonia. Am. J. Resp. Crit. Care Med. 1994; 150: 565–569.
  • Croce MA, Fabian TC, Shaw B, et al. Analysis of charges associated with diagnosis of nosocomial pneumonia: Can routine bronchoscopy be justified? J. Trauma 1994; 37: 721–727
  • Veber B, Souweine B, Gachot B, et al. Comparison of direct examination of three types of bronchoscopy specimens used to diagnose nosocomial pneumonia. Crit. Care Med. 2000; 28: 962–968.
  • Schluger NW, Rom VVN. The polymerase chain reaction in the diagnosis and evaluation of pulmonary infections. Am. J. Resp. Crit. Care Med. 1995; 142: 11–16.
  • Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process and outcomes in elderly patients with pneumonia. JAMA 1997; 278: 2080–2084.
  • Heffelfinger JD, Dowell SF, Jorgensen JH, etal. Management of community-acquired pneumonia in the era of pneumo-coccal resistance. A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch. Int. Med. 2000; 160: 1399–1408.
  • Rello J, Quintara E, Ausina V et al. Risk factors for Staphylococcus aureus nosocomial pneumonia in critically ill patients. Am. Rev. Resp. Dis. 1990; 142: 1320–1324.
  • Rello J, Torres A, Ricart M, et al. Ventilator-associated pneu-monia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am. J. Resp. Crit. Care Med. 1994; 150: 1545–1549.
  • Rello J, Austina V, Ricart M.Impact of previous antimicro-bial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993; 104: 1230–1235.
  • Robert R, Grollier G, Dore P, et al. Nosocomial pneumonia with isolation of anaerobic bacteria in ICU patients: Thera-peutic considerations and outcome. J. Crit. Care 1999; 14: 114–119.
  • Donskey CJ, Schreiber JR, Jacobs MR, et al. A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in Northeast Ohio. Clin. Infect. Dis. 1999; 29: 573–579.
  • Sieger B, Berman SJ, Geckler RW, et al. Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: A randomized study. Crit. Care Med. 1997; 25: 1663–1670.
  • Cometta A, Baumgartner JD, Lew D, et al. Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients. Antimicrob. Agents Chemother. 1994; 38: 1309–1313.
  • Chow JW, Fine MJ, Shlaes DM, etal. Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy. Ann. Intern. Med. 1991; 115: 585–590.
  • Craig W. Pharmacodynamics of antimicrobial agents as a basis for determining dosage regimens. Fur. J. Clin. Microbiol. Infect. Dis. 1993; 12: s6–s8.
  • Hatala R, Dinh T, Cook DJ. Once-daily aminoglycoside dosing in immunocompetent adults: A meta-analysis. Ann. Intern. Med. 1996; 124: 717–725.
  • Schleupner CJ, Cobb DK. A study of the etiologies and treatment of nosocomial pneumonia in a community-based teaching hospital. Infect. Control Epidem. 1992; 13: 515–525.
  • Paladino JA, Sperry HE, Backes JM et al. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. Am. J. Med. 1991; 91: 462–470.
  • Montravers P. Fagon JY, Chastre J, et al. Follow-up protected specimen brushes to assess treatment in nosocomial pneu-monia. Am. Rev. Resp. Dis. 1993; 147: 38–44.
  • Augustine G, Fein AM, Feinsilver SH, et al. When pneu-monia fails to resolve: Risk factors and diagnostic options. J. Crit. Illness 1992; 7: 213–229.
  • El-Ebiary M, Tones A, Fabrega N et al. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. Am. J. Resp. Crit. Care Med. 1997; 156: 583–590.
  • Rex JH, Walsh TJ, Sobel JD et al. Practice guidelines for the treatment of candidiasis. Clin. Infect. Dis.2000; 30: 662–676.
  • Gross PA, Hermogenes AW, Sacks HS et al. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann. Intern. Med. 1995; 123: 518–27.
  • Albert RK, Condie F. Hand-washing patterns in medical intensive care units. N. Engl. J. Med. 1981; 304: 1465–1466.
  • Rossoff LJ, Borenstein M, Isenberg HD. Is hand washing really needed in an intensive care unit? Crit. Care Med. 1995; 23: 1211–1216.
  • Craven DE, Connolly MG, Lichtenberg DA, et al. Contam-ination of mechanical ventilators with tubing changes every 24 or 48 hours. N. Engl. J. Med. 1982: 306: 1505–1509.
  • Rouby J-J, Laurent P, Gosnach M, et al. Risk factors and clinical relevance of nosocomial maxillary sinusitis in the critically ill. Am. J. Resp. Crit. Care Med. 1994; 150: 776–783.
  • Tones A, Sena-Batlles J, Ros E et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: The effect of body position. Ann. Intern. Med. 1992; 116: 540–543.
  • Kollef MH. Ventilator-associated pneumonia. A multivariate analysis. JAMA 1993; 270: 1965–1970.
  • Valles J, Artigas A, Rello J et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann. Intern. Med. 1995; 122: 179–186.
  • Fink MP, Helsmoortel CM, Stein KL et al. The efficacy of an oscillating bed in the prevention of lower respiratory tract infection in critically ill victims of blunt trauma. Chest 1990; 97: 132037.
  • DeBoisblanc BP, Castro M, Everret B et al. Effect of air-supported, continuous postural oscillation on the risk of early ICU pneumonia in nontraumatic critical illness. Chest 1993; 103: 1543–1547.
  • Souweine B, Mom T, Traore 0, et al. Ventilator-associated sinusitis. Microbiological results of sinus aspirates in patients on antibiotics. Anesthesiology 2000; 93: 1255–1260.
  • Donowitz LG, Page MC, Mileur GL et al. Alteration of normal gastric flora in critically ill patients receiving antacid and cimetidine therapy. Infect. Control Hosp. Epidemiol. 1986; 7: 23–36.
  • Driks MR, Craven DE, Celli BR et al. Nosocomial pneu-monia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. N. Engl. J. Med. 1987; 317: 1376–1382.
  • Reidy II. Ramsey G. Clinical trials of selective decontamin-ation of the digestive tract: Review. Crit. Care Med. 1990; 18: 1449–1456.
  • Cockerill FR, Muller SR, Anhalt JP, et al. prevention of infection in critically ill patients by selective decontam-ination of the digestive tract. Ann. Intern. Med. 1992; 117: 545–553.
  • Gastinne H, Wolff M, Delatour F, et al. A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. N. Engl. J. Med. 1992; 326: 594–599.
  • Ferrer M, Tones A, Gonalez J, et al. Utility of selective dig-estive decontamination in mechanically ventilated patients. Ann. Intern. Med. 1994; 120: 389–395.
  • D'Amico R, Pifferi S, Leonetti C, et al. Effectiveness of antibiotic prophylaxis in critically ill adult patients: Syst-ematic review of randomized controlled trials. BMJ 1998; 316: 1275–1285.
  • Nouira S, Elatrous S, Boukef R, et al. Effectiveness of selective digestive tract decontamination to control an outbreak of nosocomial pneumonia caused by Pseudomonas aeruginosa in mechanically ventilated patients. Clin. Int. Care 1998; 9: 180–184.
  • Ramsey BW, Pepe MS, Quan JM et al. Intermittent admin-istration of inhaled tobramycin in patients with cystic fibrosis. N. Engl. J. Med. 1999; 340: 23–30.
  • The Intravenous Immunoglobulin Collaborative Study Group. Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection. N. Engl. J. Med. 1992; 327: 234–240.
  • Welton LA, Thal LA, Perri MB, et al. Antimicrobial resis-tance in enterococci isolated from turkey flocks fed virgin-iamycin. Antimicrob. Agents Chemother. Mar 1998; 705–708.
  • Gold HS, Moellering RC: Antimicrobial drug resistance. N. Engl. J. Med . 1996; 335: 1445–1453.
  • Thomson KS, Prevan AM, Sanders CC. Novel plasmid-mediated 13-lactamases in enterobacteriaceae: Emerging problems for new b-lactam antibiotics. Curr. Clinic Topics Infect. Dis. 1996; 16: 151–163.
  • Doern GH, Pfaller MA, Kugler K, et al. Prevalence of anti-microbial resistance among respiratory tract isolates of S. pneumoniae in North America. Clin. Infect. Dis.1998; 27: 764–780.
  • Kollef MH, Vlasnik J, Sharpless L, et al. Scheduled change of antibiotic classes. A strategy of decrease the incidence of ventilator-associated pneumonia. Am. J. Resp. Crit. Care Med. 1997; 156: 1040–1048.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.